Advisors Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.2M Sell
25,085
-2,659
-10% -$1.18M 0.2% 109
2025
Q1
$13.5M Buy
27,744
+132
+0.5% +$64K 0.25% 70
2024
Q4
$11.1M Buy
27,612
+1,145
+4% +$461K 0.2% 103
2024
Q3
$12.3M Buy
26,467
+3,359
+15% +$1.56M 0.23% 88
2024
Q2
$10.8M Buy
23,108
+1,724
+8% +$808K 0.21% 102
2024
Q1
$8.94M Buy
21,384
+3,656
+21% +$1.53M 0.17% 138
2023
Q4
$7.21M Buy
17,728
+252
+1% +$103K 0.15% 166
2023
Q3
$6.08M Buy
17,476
+1,850
+12% +$643K 0.13% 186
2023
Q2
$5.5M Buy
15,626
+2,131
+16% +$750K 0.11% 207
2023
Q1
$4.25M Buy
13,495
+1,709
+15% +$538K 0.09% 286
2022
Q4
$3.4M Sell
11,786
-413
-3% -$119K 0.07% 348
2022
Q3
$3.53M Buy
12,199
+1,333
+12% +$386K 0.07% 308
2022
Q2
$3.06M Sell
10,866
-5,000
-32% -$1.41M 0.06% 365
2022
Q1
$4.14M Sell
15,866
-5,376
-25% -$1.4M 0.06% 325
2021
Q4
$4.67M Sell
21,242
-4,458
-17% -$979K 0.07% 320
2021
Q3
$4.66M Sell
25,700
-1,967
-7% -$357K 0.07% 279
2021
Q2
$5.58M Sell
27,667
-3,092
-10% -$623K 0.08% 237
2021
Q1
$6.61M Buy
30,759
+2,604
+9% +$560K 0.1% 197
2020
Q4
$6.65M Buy
28,155
+3,284
+13% +$776K 0.11% 173
2020
Q3
$6.77M Buy
24,871
+705
+3% +$192K 0.13% 150
2020
Q2
$7.02M Buy
24,166
+4,342
+22% +$1.26M 0.14% 145
2020
Q1
$4.72M Buy
19,824
+2,866
+17% +$682K 0.11% 178
2019
Q4
$3.71M Buy
16,958
+1,473
+10% +$323K 0.07% 329
2019
Q3
$2.62M Sell
15,485
-1,022
-6% -$173K 0.05% 436
2019
Q2
$3.03M Sell
16,507
-3,612
-18% -$662K 0.05% 406
2019
Q1
$3.7M Buy
20,119
+2,569
+15% +$473K 0.07% 342
2018
Q4
$2.91M Buy
17,550
+3,458
+25% +$573K 0.06% 381
2018
Q3
$2.72M Sell
14,092
-1,342
-9% -$259K 0.04% 478
2018
Q2
$2.62M Buy
15,434
+2,694
+21% +$458K 0.04% 502
2018
Q1
$2.12M Sell
12,740
-640
-5% -$106K 0.04% 582
2017
Q4
$2.01M Buy
13,380
+149
+1% +$22.3K 0.03% 612
2017
Q3
$2.01M Sell
13,231
-1,762
-12% -$268K 0.03% 606
2017
Q2
$1.93M Sell
14,993
-850
-5% -$110K 0.03% 646
2017
Q1
$1.73M Sell
15,843
-12,390
-44% -$1.35M 0.03% 681
2016
Q4
$2.08M Sell
28,233
-389
-1% -$28.7K 0.03% 630
2016
Q3
$2.5M Sell
28,622
-6,111
-18% -$533K 0.04% 555
2016
Q2
$2.99M Sell
34,733
-1,636
-4% -$141K 0.05% 529
2016
Q1
$2.89M Sell
36,369
-8,642
-19% -$687K 0.05% 533
2015
Q4
$5.66M Sell
45,011
-1,917
-4% -$241K 0.09% 319
2015
Q3
$4.89M Buy
46,928
+5,974
+15% +$622K 0.08% 355
2015
Q2
$5.06M Buy
40,954
+3,743
+10% +$462K 0.07% 384
2015
Q1
$4.39M Buy
37,211
+9,261
+33% +$1.09M 0.06% 416
2014
Q4
$3.32M Buy
27,950
+4,906
+21% +$583K 0.04% 475
2014
Q3
$2.59M Buy
23,044
+9,128
+66% +$1.03M 0.04% 523
2014
Q2
$1.32M Buy
13,916
+7,668
+123% +$726K 0.02% 738
2014
Q1
$442K Buy
6,248
+4,948
+381% +$350K 0.01% 1045
2013
Q4
$97K Buy
1,300
+100
+8% +$7.46K ﹤0.01% 1415
2013
Q3
$91K Sell
1,200
-5,800
-83% -$440K ﹤0.01% 1378
2013
Q2
$559K Buy
+7,000
New +$559K 0.01% 815